Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed

Clinical trial NCT00047333 · TERMINATED

Trial details

NCT number: NCT00047333
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Primary Hepatocellular Carcinoma Advanced Adult Primary Liver Cancer Localized Unresectable Adult Primary Liver Cancer

Start date: 2002-08-01
Primary completion: 2006-01-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.